Who Paid My Doc
Meibomian Gland Evaluator
Device
PDI 00859623006919
General payments
$229,311
Research payments
$196,842
Through program year 2025, $229,311 in general payments and $196,842 in research payments were reported against Meibomian Gland Evaluator.
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $419 | 8 |
| 2024 | General | $797 | 17 |
| 2024 | Research | $6,834 | 1 |
| 2023 | General | $42,766 | 187 |
| 2023 | Research | $63,336 | 1 |
| 2022 | General | $73,317 | 69 |
| 2022 | Research | $63,336 | 1 |
| 2021 | General | $112,012 | 125 |
| 2021 | Research | $63,336 | 1 |
Breakdown
The top 5 of 8 recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
406 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.